Browsing by Subject "Pneumococcal conjugate vaccines"

Now showing items 1-3 of 3

Changes in invasive pneumococcal disease caused by streptococcus pneumoniae serotype 1 following introduction of pcv10 and pcv13 : Findings from the pserenade project

PSERENADE Team (2021-03-27)

Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) con-taining ST1 antigen. The Pneumococcal Serotype Replacement and ...
Global landscape review of serotype-specific invasive pneumococcal disease surveillance among countries using PCV10/13 : The pneumococcal serotype replacement and distribution estimation (PSERENADE) project

PSERENADE Team (2021-04-02)

Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) ...
The population impact and cost-effectiveness of the 10-valent pneumococcal conjugate vaccine in Iceland

Eyþórsson, Elías (University of Iceland, School of Health Sciences, Faculty of Medicine, 2019-06-05)

Streptococcus pneumoniae is a Gram-positive diplococcus that is both a commensal bacterium in the upper respiratory tract of humans, and a common pathogen. The infectious manifestations of pneumococci span a range from benign to serious; from acute ...

Now showing items 1-3 of 3

Search Opin vísindi